Literature DB >> 28377170

Antiplasmodial activity of targeted zinc(II)-dipicolylamine complexes.

Douglas R Rice1, María de Lourdes Betancourt Mendiola1, Claribel Murillo-Solano2, Lisa A Checkley3, Michael T Ferdig3, Juan C Pizarro2, Bradley D Smith4.   

Abstract

This study measured the antiplasmodial activity of nine zinc-dipicolylamine (ZnDPA) complexes against three strains of Plasmodium falciparum, the causative parasite of malaria. Growth inhibition assays showed significant activity against all tested strains, with 50% inhibitory concentrations between 5 and 600nM and almost no toxic effect against host cells including healthy red blood cells. Fluorescence microscopy studies with a green-fluorescent ZnDPA probe showed selective targeting of infected red blood cells. The results suggest that ZnDPA coordination complexes are promising antiplasmodial agents with potential for targeted malaria treatment.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antiplasmodial drugs; Fluorescence microscopy; Malaria; Zinc dipicolylamine

Mesh:

Substances:

Year:  2017        PMID: 28377170      PMCID: PMC5443346          DOI: 10.1016/j.bmc.2017.03.050

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  33 in total

Review 1.  Ferrocene-based antimalarials.

Authors:  Clément Roux; Christophe Biot
Journal:  Future Med Chem       Date:  2012-04       Impact factor: 3.808

2.  Online analysis of in vitro resistance to antimalarial drugs through nonlinear regression.

Authors:  Hervé Le Nagard; Corine Vincent; France Mentré; Jacques Le Bras
Journal:  Comput Methods Programs Biomed       Date:  2010-09-09       Impact factor: 5.428

3.  Immunoliposome-mediated drug delivery to Plasmodium-infected and non-infected red blood cells as a dual therapeutic/prophylactic antimalarial strategy.

Authors:  Ernest Moles; Patricia Urbán; María Belén Jiménez-Díaz; Sara Viera-Morilla; Iñigo Angulo-Barturen; Maria Antònia Busquets; Xavier Fernàndez-Busquets
Journal:  J Control Release       Date:  2015-05-23       Impact factor: 9.776

4.  Tracing the geographic origins of Plasmodium falciparum malaria parasites.

Authors:  Xin-zhuan Su
Journal:  Pathog Glob Health       Date:  2014-09       Impact factor: 2.894

5.  Zinc(II)-Dipicolylamine Coordination Complexes as Targeting and Chemotherapeutic Agents for Leishmania major.

Authors:  Douglas R Rice; Paola Vacchina; Brianna Norris-Mullins; Miguel A Morales; Bradley D Smith
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

6.  Synthesis and in vitro antiprotozoal activities of dicationic 3,5-diphenylisoxazoles.

Authors:  Donald A Patrick; Stanislav A Bakunov; Svetlana M Bakunova; E V K Suresh Kumar; Richard J Lombardy; Susan Kilgore Jones; Arlene S Bridges; Oksana Zhirnov; James Edwin Hall; Tanja Wenzler; Reto Brun; Richard R Tidwell
Journal:  J Med Chem       Date:  2007-04-18       Impact factor: 7.446

7.  Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.

Authors:  Chanaki Amaratunga; Pharath Lim; Seila Suon; Sokunthea Sreng; Sivanna Mao; Chantha Sopha; Baramey Sam; Dalin Dek; Vorleak Try; Roberto Amato; Daniel Blessborn; Lijiang Song; Gregory S Tullo; Michael P Fay; Jennifer M Anderson; Joel Tarning; Rick M Fairhurst
Journal:  Lancet Infect Dis       Date:  2016-01-08       Impact factor: 25.071

8.  Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans.

Authors:  Stanislav A Bakunov; Svetlana M Bakunova; Tanja Wenzler; Todd Barszcz; Karl A Werbovetz; Reto Brun; Richard R Tidwell
Journal:  J Med Chem       Date:  2008-10-09       Impact factor: 7.446

9.  Enhanced cell death imaging using multivalent zinc(II)-bis(dipicolylamine) fluorescent probes.

Authors:  Bryan A Smith; Kara M Harmatys; Shuzhang Xiao; Erin L Cole; Adam J Plaunt; William Wolter; Mark A Suckow; Bradley D Smith
Journal:  Mol Pharm       Date:  2013-08-05       Impact factor: 4.939

Review 10.  The antimalarial ferroquine: from bench to clinic.

Authors:  C Biot; F Nosten; L Fraisse; D Ter-Minassian; J Khalife; D Dive
Journal:  Parasite       Date:  2011-08       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.